Guangxi Wuzhou Zhongheng Group Co Ltd - Asset Resilience Ratio
Guangxi Wuzhou Zhongheng Group Co Ltd (600252) has an Asset Resilience Ratio of 0.77% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 600252 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2025)
This chart shows how Guangxi Wuzhou Zhongheng Group Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 600252 total assets.
Liquid Assets Composition Over Time
This chart breaks down Guangxi Wuzhou Zhongheng Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 600252 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥78.93 Million | 0.77% |
| Total Liquid Assets | CN¥78.93 Million | 0.77% |
Asset Resilience Insights
- Limited Liquidity: Guangxi Wuzhou Zhongheng Group Co Ltd maintains only 0.77% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Guangxi Wuzhou Zhongheng Group Co Ltd Industry Peers by Asset Resilience Ratio
Compare Guangxi Wuzhou Zhongheng Group Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM |
Drug Manufacturers - Specialty & Generic | 2.79% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 2.51% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Harbin Pharmaceutical Group Co Ltd
SHG:600664 |
Drug Manufacturers - Specialty & Generic | 0.97% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Annual Asset Resilience Ratio for Guangxi Wuzhou Zhongheng Group Co Ltd (2009–2025)
The table below shows the annual Asset Resilience Ratio data for Guangxi Wuzhou Zhongheng Group Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.77% | CN¥77.02 Million ≈ $11.27 Million |
CN¥10.07 Billion ≈ $1.47 Billion |
-0.06pp |
| 2024-12-31 | 0.82% | CN¥90.26 Million ≈ $13.21 Million |
CN¥10.98 Billion ≈ $1.61 Billion |
-4.54pp |
| 2023-12-31 | 5.36% | CN¥625.87 Million ≈ $91.58 Million |
CN¥11.67 Billion ≈ $1.71 Billion |
-0.17pp |
| 2022-12-31 | 5.53% | CN¥650.41 Million ≈ $95.18 Million |
CN¥11.75 Billion ≈ $1.72 Billion |
-6.03pp |
| 2021-12-31 | 11.56% | CN¥1.37 Billion ≈ $201.18 Million |
CN¥11.89 Billion ≈ $1.74 Billion |
+0.51pp |
| 2018-12-31 | 11.05% | CN¥800.00 Million ≈ $117.07 Million |
CN¥7.24 Billion ≈ $1.06 Billion |
-4.54pp |
| 2017-12-31 | 15.59% | CN¥1.07 Billion ≈ $156.57 Million |
CN¥6.86 Billion ≈ $1.00 Billion |
+15.57pp |
| 2009-12-31 | 0.02% | CN¥321.09K ≈ $46.98K |
CN¥1.50 Billion ≈ $220.16 Million |
-- |
About Guangxi Wuzhou Zhongheng Group Co Ltd
Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for … Read more